a clinical-stage biopharmaceutical company
Industry AerospaceDefense
A.I.dvisor tells us that AXON and DRS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AXON and DRS's prices will move in lockstep.
Ticker / NAME | Correlation To AXON | 1D Price Change % | ||
---|---|---|---|---|
AXON | 100% | +2.60% | ||
DRS - AXON | 30% Poorly correlated | +3.22% | ||
CMGMF - AXON | 30% Poorly correlated | N/A | ||
KTOS - AXON | 28% Poorly correlated | +1.05% | ||
AIR - AXON | 27% Poorly correlated | -0.05% | ||
CAE - AXON | 27% Poorly correlated | +4.16% | ||
More |